For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Caredx Inc’s stock clocked out at $32.16, down -0.12% from its previous closing price of $32.20. In other words, the price has decreased by -$0.12 from its previous closing price. On the day, 0.85 million shares were traded. CDNA stock price reached its highest trading level at $32.62 during the session, while it also had its lowest trading level at $31.13.
Ratios:
To gain a deeper understanding of CDNA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 4.09. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Underweight rating and assigned the stock a target price of $28.
On August 19, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $40.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 20 ’24 when Johnson Alexander L sold 39,466 shares for $33.17 per share. The transaction valued at 1,309,087 led to the insider holds 284,983 shares of the business.
Johnson Alexander L sold 21,557 shares of CDNA for $702,327 on Aug 21 ’24. The insider now owns 284,983 shares after completing the transaction at $32.58 per share. On Aug 20 ’24, another insider, Maag Peter, who serves as the Director of the company, sold 35,552 shares for $33.04 each. As a result, the insider received 1,174,493 and left with 330,024 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1696118400 and an Enterprise Value of 1498695680. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.71 while its Price-to-Book (P/B) ratio in mrq is 6.39. Its current Enterprise Value per Revenue stands at 5.045 whereas that against EBITDA is -24.036.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 11.58%, while the 200-Day Moving Average is calculated to be 99.41%.
Shares Statistics:
It appears that CDNA traded 914.95K shares on average per day over the past three months and 823670 shares per day over the past ten days. A total of 51.50M shares are outstanding, with a floating share count of 49.35M. Insiders hold about 6.43% of the company’s shares, while institutions hold 96.89% stake in the company. Shares short for CDNA as of 1726185600 were 3659670 with a Short Ratio of 4.00, compared to 1723680000 on 3206046. Therefore, it implies a Short% of Shares Outstanding of 3659670 and a Short% of Float of 9.2.
